Crossref
FDA Advises Against Over-the-Counter Skin Lightening Products
JAMA · 14.07.2026 · 336 (2) · 96
DOI: 10.1001/jama.2026.8311 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 14.07.2026. Verfasst von Samantha Anderer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Anderer, S. (2026). FDA Advises Against Over-the-Counter Skin Lightening Products. JAMA, 336(2), 96. https://doi.org/10.1001/jama.2026.8311
Vancouver
Anderer S. FDA Advises Against Over-the-Counter Skin Lightening Products. JAMA. 2026;336(2):96. doi:10.1001/jama.2026.8311
BibTeX
@article{Anderer2026,
author = {Anderer, Samantha},
title = {FDA Advises Against Over-the-Counter Skin Lightening Products},
journal = {JAMA},
year = {2026},
volume = {336},
number = {2},
pages = {96},
doi = {10.1001/jama.2026.8311}
}
EUVIMED